HydRx Wellness is pleased to announce receipt of a Drug Establishment License (DEL) issued by Health Canada in accordance with the Food and Drugs Act and it’s Regulations.
Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics, is pleased to announce the appointment of James Williams to its Board as an independent nonexecutive director, effective 16 September 2024.
PayToMe.co, a leading innovator in AI-driven financial solutions, is proud to announce it has been named the Best Ethical FinTech Firm – North America by Wealth & Finance International.
According to the report, the global cancer biomarkers industry was estimated at $10.94 billion in 2019, and is expected to hit $26.97 billion by 2027, registering a CAGR of 11.
OBiS, a New York City-based healthcare analytics consulting firm, has developed a pre-meeting report based on the abstract titles from the upcoming European Society of Medical Oncology (ESMO) congress.
GPN Vaccines Ltd is pleased to announce that the first participant has been dosed in its Phase 1 clinical trial of Gamma-PN vaccine in older adults. The Phase 1 clinical trial will assess the safety, tolerability and immunogenicity of Gamma-PN.
SourceFuse, a strategic digital transformation company helping businesses evolve through cloud-native technologies and an Amazon Web Services (AWS) Premier Tier Services Partner in the AWS Partner Network (APN), announced today that it has achieved the AWS Small and Medium Business Competency.
